dvm36017h
Laverdia-CA1's field trial ends, statistical analysis to begin
Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the ...
Investigation turns up an Illicit drug in a dozen racehorses following the high-stakes All American
New Mexico regulators have suspended two prominent horse trainers after tests turned up a banned medication in a dozen ...
Elanco receives FDA warning letter over Zenrelia marketing
Elanco Animal Health (NYSE:ELAN) has received a warning letter from the FDA related to promotional materials for its canine drug Zenrelia. In the letter, the FDA said that an agency review of certain ...